Hermetica Superfood Encyclopedia
The Short Answer
Phyllanthus niruri contains lignans (chiefly hypophyllanthin, niranthin, and phyllanthin), phenolics, flavonoids, and tannins that exert antioxidant, hepatoprotective, and antimicrobial effects through free-radical scavenging, enzyme inhibition, and bacterial cell-target binding. In vitro evidence demonstrates DPPH radical scavenging with an IC50 of 56.72 ppm for whole-plant extract, bactericidal activity at MIC values of 62.5–250 µg/mL against Staphylococcus aureus, and encapsulated phyllanthin retention of 84.33% using whey protein isolate:maltodextrin matrices, though robust human clinical trial data remain absent.
CategoryHerb
GroupSoutheast Asian
Evidence LevelPreliminary
Primary Keyworddukung anak benefits
Dukung Anak — botanical close-up
Health Benefits
**Antioxidant Protection**
The methanol fraction yields a total phenolic content of 119.10 ± 0.11 µg GAE/g and total flavonoid content of 128.01 ± 0.11 µg QE/g; hypophyllanthin is strongly correlated with DPPH radical scavenging activity in 80% ethanol extracts, providing cellular protection against oxidative stress.
**Hepatoprotection**
Lignans including phyllanthin, hypophyllanthin, and corilagin are traditionally and pharmacologically associated with liver-protective effects; these compounds modulate oxidative pathways and have demonstrated activity against hepatotoxic agents in preclinical models, supporting traditional use for liver disorders.
**Kidney Stone Management**
Phyllanthus niruri has longstanding traditional use for nephrolithiasis across Southeast Asian and South American ethnomedicine; bioactive phenolics and lignans are proposed to inhibit calcium oxalate crystal aggregation and promote urinary electrolyte modulation, supported by an animal study showing significant (p<0.05) increases in plasma Na⁺ and HCO₃⁻ versus control.
**Antimicrobial Activity**
Extracts exhibit bactericidal activity against Staphylococcus aureus at MIC 62.5–125 µg/mL and against Gram-negative bacteria and Candida albicans at up to 250 µg/mL, with molecular docking identifying benzeneacetamide (−9.4 kcal/mol) and 3-(3,4-dimethoxyphenyl)-propionic acid (−8.7 kcal/mol) as potent inhibitors of DNA gyrase and penicillin-binding protein 1B.
**Antiplasmodial Effects**
Chloroform and ethanol extracts inhibit the in vitro growth of Plasmodium falciparum, consistent with traditional use of the herb in malaria-endemic communities of Indonesia and Malaysia; the exact active fraction responsible for antiplasmodial activity has not yet been fully isolated.
**Alpha-Glucosidase Inhibition and Antidiabetic Potential**
Hypophyllanthin and associated phenolics inhibit α-glucosidase activity in vitro through phenolic-enzyme interactions, suggesting a mechanism for postprandial blood glucose reduction; this aligns with traditional use of the plant for metabolic disorders, though clinical validation is lacking.
**Anticancer and Antiviral Preclinical Activity**
Lignans and terpenes identified by GC-MS, including phytol, linolenic acid, and nirtetralin, are documented in the broader Phyllanthus genus literature as having antiviral (including anti-hepatitis B) and antiproliferative properties at the cellular level, though these effects for P. niruri specifically require further mechanistic and clinical investigation.
Origin & History
Natural habitat
Phyllanthus niruri L. is a small, erect annual herb native to tropical and subtropical regions of Southeast Asia, South Asia, and the Americas, growing abundantly in Malaysia, Indonesia (including Aceh province), India, and Brazil. It thrives in moist, disturbed habitats including roadsides, community yards, rice paddies, and forest margins at low to moderate elevations, often treated as a common weed. The plant reaches 30–50 cm in height and is typically harvested from wild or semi-cultivated community garden sources for both traditional medicine and research applications.
“Phyllanthus niruri has been used for centuries across Southeast Asian, South Asian, and Amazonian traditional medicine systems under numerous regional names — dukung anak in Malaysia and Indonesia, chanca piedra ('stone breaker') in Peru and Brazil, bhuiamalaki in Ayurvedic medicine, and zhenzhu cao in Chinese folk medicine. In Aceh, Indonesia, the plant is harvested from community yards and used as a household remedy for liver ailments, infections, and febrile illnesses associated with malaria-endemic environments, reflecting deep integration into daily health practice. Brazilian traditional healers have long prescribed chanca piedra specifically for nephrolithiasis and hepatitis, a use that drew the attention of ethnopharmacologists in the 1980s–1990s and catalyzed the first wave of laboratory investigation into the genus Phyllanthus. The plant's global distribution across tropical regions has led to parallel, independent ethnomedicinal traditions converging on similar indications — particularly liver and kidney disease — which is considered strong ethnobotanical validation supporting continued pharmacological research.”Traditional Medicine
Scientific Research
The current evidence base for Phyllanthus niruri consists predominantly of in vitro biochemical assays, GC-MS phytochemical characterization studies, and limited animal experiments, with no peer-reviewed human randomized controlled trials identified in available search results. In vitro antimicrobial studies quantify MIC and MBC values across multiple bacterial and fungal strains, and DPPH radical-scavenging assays provide reproducible IC50 data (56.72 ppm); however, these surrogate endpoints do not directly translate to clinical efficacy. One animal electrolyte study demonstrated statistically significant (p<0.05) increases in plasma Na⁺ and HCO₃⁻ compared to control, offering preliminary mechanistic support for anti-urolithiatic use, but sample sizes and species details are not fully reported in available summaries. The overall evidence quality is low-to-preliminary; while the pharmacological rationale for kidney stone and hepatoprotective applications is biologically plausible, clinical confirmation through adequately powered human trials is absent, and results should be interpreted with caution.
Preparation & Dosage
Traditional preparation
**Traditional Decoction**
30–50 g fresh or 10–15 g dried) boiled in water for 15–20 minutes; consumed as a tea 1–2 times daily in traditional Indonesian and Malaysian practice for liver and kidney complaints
Whole aerial parts (.
**Methanol/Ethanol Extract (Research Grade)**
Used at 50–250 µg/mL in in vitro studies; 80% ethanol maximizes hypophyllanthin and total flavonoid extraction and is the solvent of choice for antioxidant-standardized preparations.
**Ethyl Acetate Fraction**
Yields TPC 102.06 µg GAE/g and TFC 109.09 µg QE/g; used in antimicrobial research at MIC-equivalent concentrations of 62.5–250 µg/mL.
**Encapsulated Powder (Emerging Form)**
Whey protein isolate:maltodextrin (1:9) encapsulation retains phyllanthin at 84.33%, gallic acid at 88.93%, and quercetin at 88.39%; represents a promising oral supplement form for standardized dosing, though clinical dose ranges are not yet established.
**Standardization Note**
No pharmacopoeial or regulatory standardized dose has been established for human supplementation; commercial products in Southeast Asia vary widely in extract concentration and are not uniformly standardized to phyllanthin or hypophyllanthin content.
**Timing**
Traditional use is not time-restricted; preliminary pharmacological rationale for kidney stone applications suggests consumption with adequate water intake to maximize urinary dilution effects.
Nutritional Profile
Phyllanthus niruri is not consumed as a dietary staple and therefore lacks macronutrient significance; its nutritional relevance lies entirely in its dense phytochemical profile. Key bioactive phytochemicals include lignans (hypophyllanthin, phyllanthin, niranthin, nirtetralin, phyltetralin, phyllangin, nirphyllin, phyllnirurin), ellagitannins (corilagin), phenolic acids (gallic acid, 3-(3,4-dimethoxyphenyl)-propionic acid), flavonoids (quercetin and derivatives; TFC up to 128.01 µg QE/g in methanol fraction), and alkaloids. Fatty acid constituents identified by GC-MS include hexadecanoic acid (palmitic acid) and linolenic acid (an essential omega-3), alongside the diterpene alcohol phytol and the Maillard-reaction product 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one. Total phenolic content peaks at 119.10 µg GAE/g in the methanol fraction; polar protic solvents (methanol, 80% ethanol) significantly outperform non-polar solvents in extracting phenolics and flavonoids, making solvent choice a critical bioavailability determinant for supplement preparation.
How It Works
Mechanism of Action
The antioxidant activity of Phyllanthus niruri is primarily mediated by phenolic hydroxyl groups in flavonoids, tannins, and lignans — particularly hypophyllanthin — that donate hydrogen atoms to neutralize DPPH and other reactive oxygen species, achieving an IC50 of 56.72 ppm in whole-plant extract. Antimicrobial effects operate through dual bacterial targets: molecular docking studies indicate that benzeneacetamide (3,4-dimethoxy-substituted) binds DNA gyrase with a binding energy of −9.4 kcal/mol, disrupting DNA supercoiling, while 3-(3,4-dimethoxyphenyl)-propionic acid binds penicillin-binding protein 1B at −8.7 kcal/mol, impairing cell wall peptidoglycan cross-linking, with bactericidal thresholds confirmed by MBC/MIC ratios ≤4. Hypophyllanthin also inhibits α-glucosidase through non-covalent phenolic interactions at the enzyme's active site, thereby slowing intestinal glucose release, while corilagin and related ellagitannins are proposed to modulate hepatic oxidative and inflammatory pathways relevant to hepatoprotection. Electrolyte modulation observed in animal studies — elevated plasma Na⁺ and HCO₃⁻ — suggests additional renal tubular effects that may contribute to the anti-urolithiatic mechanism by alkalinizing urine and reducing calcium oxalate supersaturation.
Clinical Evidence
No human clinical trials with defined sample sizes, control arms, or reported effect sizes for Phyllanthus niruri have been identified in the current evidence review. The most relevant quasi-clinical data come from an animal model demonstrating electrolyte changes (elevated Na⁺ and HCO₃⁻, p<0.05) that are mechanistically consistent with urinary alkalinization relevant to kidney stone dissolution. Encapsulation technology studies confirm that phyllanthin (84.33%), gallic acid (88.93%), and quercetin (88.39%) are retained in whey protein isolate:maltodextrin (1:9) matrices, establishing a formulation pathway for standardized delivery, but this has not been tested in human bioavailability trials. Confidence in clinical outcomes remains very low; practitioners and formulators should rely on the preclinical mechanistic evidence as hypothesis-generating until human trial data are available.
Safety & Interactions
Phyllanthus niruri demonstrates low acute toxicity in bioassay screening, with an LC50 of 532.96 ppm placing it in the low-toxicity category by Mayer's brine shrimp classification; no significant cytotoxicity has been reported at typical extract concentrations used in antimicrobial or antioxidant assays. No formal human clinical safety trials, adverse event reporting systems, or established tolerable upper intake levels exist in the current literature, meaning that side effects, drug interactions, and contraindications in humans are not well characterized. Theoretical drug interaction concerns include potential additive effects with antidiabetic medications (due to α-glucosidase inhibition by hypophyllanthin), diuretics or electrolyte-modifying drugs (based on observed Na⁺/HCO₃⁻ changes in animal studies), and anticoagulants (due to phenolic content with potential platelet effects), though these interactions have not been confirmed in human studies. Pregnant and lactating women, individuals with chronic kidney or liver disease, and those on prescription medications should avoid unsupervised use until safety data from human trials are available; the plant's traditional reputation as a uterine stimulant in some folk systems warrants caution in pregnancy.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Phyllanthus niruri L.Chanca piedraBhuiamalakiStone breakerMeniranZhenzhu caoSeed-under-leaf
Frequently Asked Questions
What is dukung anak used for traditionally?
Dukung anak (Phyllanthus niruri) is used in Malaysian and Indonesian traditional medicine primarily for kidney stones, liver disorders, malaria, and bacterial infections, reflecting a practice spanning centuries across Southeast Asia and Amazonian South America. The plant's lignans — phyllanthin, hypophyllanthin, and corilagin — are considered the key bioactives behind its hepatoprotective and anti-urolithiatic reputation, and it is commonly prepared as a water decoction of the whole aerial plant.
Does Phyllanthus niruri actually dissolve kidney stones?
Clinical human trial evidence for Phyllanthus niruri dissolving kidney stones is currently absent; available support comes from traditional ethnobotanical use and one animal study demonstrating significant increases in plasma Na⁺ and HCO₃⁻ (p<0.05) consistent with urinary alkalinization, which may reduce calcium oxalate crystal formation. The plant's bioactive phenolics and lignans are pharmacologically plausible as anti-urolithiatic agents, but adequately powered randomized controlled trials in humans are needed before clinical recommendations can be made.
What are the main active compounds in Phyllanthus niruri?
The principal bioactive compounds in Phyllanthus niruri are the lignans hypophyllanthin, phyllanthin, niranthin, nirtetralin, phyltetralin, and corilagin, alongside phenolic acids, flavonoids (including quercetin), tannins, and fatty acids such as hexadecanoic acid and linolenic acid. Hypophyllanthin is particularly important as it correlates strongly with both DPPH antioxidant activity and α-glucosidase inhibition in 80% ethanol extracts, making it a candidate marker compound for extract standardization.
Is dukung anak safe to consume as a supplement?
Phyllanthus niruri shows low acute toxicity in laboratory bioassays (LC50 532.96 ppm, brine shrimp assay), and no serious adverse effects have been reported at typical in vitro or traditional use concentrations. However, no human safety trials have been conducted, so formal contraindications, drug interactions (particularly with antidiabetics, diuretics, or anticoagulants), and safe upper dose limits remain undefined; pregnant women and individuals on prescription medications should consult a healthcare provider before use.
How is Phyllanthus niruri best extracted and what form should I take?
Polar protic solvents — particularly 80% ethanol and methanol — yield the highest total phenolic content (up to 119.10 µg GAE/g) and total flavonoid content (up to 128.01 µg QE/g) from Phyllanthus niruri, making ethanolic or methanolic extracts preferable for antioxidant and hepatoprotective applications. Encapsulation in a whey protein isolate:maltodextrin (1:9) matrix has been shown to retain phyllanthin at 84.33%, gallic acid at 88.93%, and quercetin at 88.39%, representing a promising oral supplement form, though no standardized human dose has been clinically established.
What is the difference between Phyllanthus niruri extract forms in terms of antioxidant potency?
Methanol and 80% ethanol extracts of Phyllanthus niruri show the highest antioxidant activity, with hypophyllanthin being the primary compound responsible for DPPH radical scavenging. The methanol fraction yields approximately 119 µg GAE/g of total phenolics and 128 µg QE/g of flavonoids, making it significantly more potent than water or lower-concentration alcohol extracts. Choosing a standardized extract with measured phenolic and flavonoid content ensures consistent antioxidant benefits across different batches.
Does Phyllanthus niruri help protect liver health, and what compounds are responsible?
Yes, Phyllanthus niruri contains lignans including phyllanthin and hypophyllanthin that have demonstrated hepatoprotective properties in traditional use and preliminary research. These compounds support liver function through both antioxidant mechanisms and direct cellular protection, making dukung anak a popular choice in traditional medicine for liver support. However, human clinical evidence is still limited, so supplementation should complement rather than replace conventional medical advice for liver conditions.
Are there specific populations for whom Phyllanthus niruri antioxidant benefits may be most valuable?
Individuals with elevated oxidative stress—such as those with chronic inflammatory conditions, liver concerns, or kidney health issues—may benefit most from Phyllanthus niruri's strong DPPH radical scavenging activity and high phenolic content. Athletes and those exposed to environmental toxins may also benefit from the herb's cellular protection mechanisms. Those already on antioxidant medications or supplements should consult a healthcare provider to avoid redundant supplementation.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w dukung-anak-phyllanthus-niruri-l curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
